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Articular cartilage injuries have been observed with increasing 
frequency in collegiate, professional, and world-class foot-
ball players and may be associated with the increased rate of 
joint degeneration and disability in the football population.1-6 
To assure continued sports activity without risking joint 
degeneration and long-term disability, durable articular carti-
lage resurfacing is critically relevant for the football athlete 
with articular cartilage injury. Successful repair of articular 
cartilage lesions of the human knee by autologous chondro-
cyte implantation (ACI) was first reported by Brittberg in 
19947 and has demonstrated excellent results after up to 
20 years in the general population.7,8 Because of the relative 
invasiveness of the first-generation technique, its long reha-
bilitation time, and complications resulting from the use of 
periosteum, researchers have aimed to reduce these limita-
tions through continued improvement and development of 
this technique and its postoperative rehabilitation. This article 
provides an overview of the gradual evolution of ACI since 
its first introduction and describes how these innovations 
may affect postoperative sports participation in football 
players with articular cartilage defects.
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Abstract
Background: Autologous chondrocyte implantation (ACI) continues to technically evolve, but how the technical innovations 
affect the ability to participate in high-impact sports such as football is unknown. Methods: Clinical studies describing 
athletes treated with first-, second-, or third-generation ACI techniques were reviewed. The technical developments of ACI 
were evaluated, and the results in athletes and specifically football (soccer) players were analyzed. Results: Football players 
reported 72% good to excellent results with significant overall improvement of knee function and activity scores. Return 
to football was 83% in competitive players but lower in recreational players. Eighty percent of players returned to the same 
competitive level after ACI, and 87% to 100% maintained their ability to play sports at 5 years postoperatively. Return to 
sport was better for younger, competitive players with shorter intervals between injury and ACI. New developments of the 
surgical technique and postoperative rehabilitation were able to reduce the limitations associated with first-generation ACI 
including invasiveness, graft hypertrophy, and particularly long postoperative rehabilitation. This allowed for faster return to 
sports like football without compromising the ability for continued competition over time. Conclusion: Articular cartilage 
repair in football players often allows for successful return to this high-impact sport with excellent durability. The continued 
evolution of this technique has improved initial shortcomings with important implications for both the professional and 
recreational athlete.
Keywords
sports injury < diagnosis, cartilage repair < repair, autologous chondrocyte < grafts, knee < joint involved, articular cartilage < 
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Technical Evolution of ACI
First-Generation Technique
With this original ACI technique, cartilage harvesting was 
performed in a primary procedure, followed by cell isolation 
and expansion in vitro. Implantation of the cultured chon-
drocytes was then performed in a second open procedure 
under a periosteal patch acquired from the proximal tibia 
and sutured to the surrounding stable cartilage margins with 
the cambium layer facing toward the defect.7 The periosteal 
rim was sealed with fibrin glue, and the cultured chondro-
cytes were then injected under the periosteal flap covering 
the articular cartilage defect. This procedure often required 
a large incision for access to the defect and periosteal har-
vest (Fig. 1). The results of this first-generation technique 
have been described specifically for football players.9 Good 
and excellent results were reported in 72% overall, in 85% 
of players with single cartilage lesions, and in 93% of single 
defects located on the medial femoral condyle. Postoperative 
Tegner activity scores improved in 82% from an average 
3.6 ± 0.2 points preoperatively to 6.1 ± 0.5 points at last 
follow-up (P < 0.001). While overall rate to return to foot-
ball was 33%, return rate was significantly better for com-
petitive players at 83% compared to 16% in recreational 
players (P < 0.001). Best return rates were observed in ado-
lescent athletes with a return rate of 96%.10 Eighty percent 
of returning players returned to the preinjury skill level. 
Average time to return to football was 18 months (range, 
12-24 months) for first-generation ACI. Time to return was 
shorter in high-level soccer players (14 months) than in 
recreational players (22 months) (P < 0.001). Of the return-
ing players, 87% continued to play 52 months after ACI.
Return to football was significantly better in players with 
single cartilage lesions of the femur, younger age (≤25 years), 
and players who underwent ACI early (<12 months after 
injury). In fact, the ability to return to playing football was 
4 times higher when ACI was performed within 1 year after 
injury (Table 1). No significant association was found 
between return to football and gender, defect type, defect 
location, defect size, or number of prior surgeries. 
Concomitant procedures such as ligament reconstructions 
or osteotomies did not decrease the ability to return to foot-
ball, as 56% of players with osteotomies were able to 
return to play football. Interestingly, postoperative partici-
pation in athletic activities improved the long-term func-
tional results after first-generation ACI.11 The failure rate 
was 13%, with half of the failures resulting from traumatic 
delamination of hypertrophic grafts.
Characterized Chondrocyte Implantation
The in vitro culture and expansion of human chondrocytes 
for ACI have been shown to result in a dedifferentiation of 
the cultured cells with a shift from a predominantly type II 
collagen-containing hyaline matrix to a fibrocartilage-like 
type I collagen-rich repair cartilage.12,13 To address this aspect, 
characterized chondrocyte implantation (CCI) has been 
developed to improve hyaline articular cartilage regenera-
tion through the identification and selective expansion of 
specific chondrocyte subpopulations capable of producing 
more hyaline-like repair cartilage tissue. CCI uses the first-
generation ACI surgical technique with a periosteal patch. 
Prospective, randomized, controlled clinical comparison 
of CCI with microfracture has shown superior structural 
repair and histomorphometry with CCI at 12 months.12 
Clinical results at 36 months have shown significantly 
increased Knee injury and Osteoarthritis Outcome Score 
(KOOS) sports and recreation subscores that were higher 
than after microfracture.13 Better KOOS sports subscores 
were seen when surgery was performed within 3 years from 
injury. Recently discussed results show a persistent good 
outcome at 5 years, and prospective cohort data using CCI 
with a synthetic membrane clearly demonstrate a reduction 
of hypertrophy compared to periosteal coverage.14 The same 
authors found significant increases of the Activity Rating 
Scale after CCI and that low-level joint-loading activities 
after surgery had a beneficial effect on postoperative recov-
ery with both faster return to preinjury activity levels and 
significantly better overall knee function. Graft hypertrophy 
was observed in 25% after CCI, with a failure rate of 4% at 
36 months.13,15
Second-Generation Techniques
To avoid the frequent complication of graft hypertrophy and 
the associated risk from delamination or requirement for 
surgical chondroplasty of the hypertropic graft, bioab-
sorbable collagen membrane was developed as an innovative 
Figure 1. Intraoperative image of a football player treated 
with first-generation autologous chondrocyte implantation, 
demonstrating a full arthrotomy and sutured periosteal patch.
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temporary cover of the treated defect instead of the autolo-
gous periosteal patch. This so-called collagen-covered ACI 
(CACI) had the advantage of reducing the invasiveness of 
the procedure; however, it still required an arthrotomy and 
suturing of the collagen membrane into the defect (Fig. 2). 
Clinical results were similar to first-generation ACI, but 
this technique was able to reduce the incidence of graft 
hypertrophy to 6%.16
Third-Generation Techniques
The so-called third-generation ACI techniques use biode-
gradable membranes or scaffolds to temporarily support the 
chondrocytes until they are replaced by neocartilage matrix 
components synthesized from the implanted cells. These 
techniques involve attachment or “seeding” of the cul-
tured chondrocytes into type I/III collagen membranes or 
3-dimensional scaffolds and avoid the need for the perios-
teum. Scaffolds and membranes can be based on carbohy-
drates (polylactic/polyglycolic acid, hyaluronan, agarose, 
alginate), protein polymers (collagen, fibrin, gelatin), artifi-
cial polymers (carbon fiber, hydroxyapatite, Teflon, polybu-
tyric acid), or composite polymer matrices.
Matrix-induced ACI (MACI) uses a biomatrix seeded 
with chondrocytes and further reduces surgical invasiveness, 
perioperative morbidity, and risk for complications such as 
scarring and arthrofibrosis17 (Fig. 3). It also has the theoreti-
cal advantages of less chondrocyte leakage and more homo-
geneous chondrocyte distribution. This technique can be 
performed through a mini-arthrotomy using fibrin glue for 
fixation of the cell-seeded membrane into the defect. Clinical 
results have shown significant increases in KOOS sports and 
recreation subscores and Tegner activity scores at 2-year 
follow-up.17,18 Specific information on return to sport in the 
athletic population or football players is not available. The 
MACI technique has been associated with a reduction of 
graft hypertrophy to 7%.16 Biopsy at 12 months showed evi-
dence of hyaline-like tissue, and magnetic resonance imaging 
(MRI) showed good defect filling. Arthroscopic MACI has 
been described with a hyaluronic acid–based scaffold and 
showed significant improvement of knee function in 90% of 
the athletic population after 5 years19,20 (Fig. 4). Significant 
improvement of Tegner activity scores was observed during 
Figure 2. Intraoperative image of collagen membrane autologous 
chondrocyte implantation (CACI) using mini-arthrotomy and suture 
fixation of the collagen membrane. 
Figure 3. Intraoperative image of matrix-induced autologous 
chondrocyte implantation (MACI) using a minimally invasive 
technique with fibrin glue fixation of the chondrocyte-seeded 
matrix.
Figure 4. Intraoperative image of arthroscopic autologous 
chondrocyte implantation using a 3-dimensional hyaluronic acid 
scaffold seeded with chondrocytes covering the cartilage defect. 
From Kon et al.19
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the first 2 years, with 100% durability of the functional 
improvement until 5 years after implantation. The athlete’s 
age significantly correlated with the ability to resume sports 
activity. Concomitant procedures like anterior cruciate liga-
ment (ACL) reconstruction were associated with the same 
incidence and durability of the functional improvement and 
same rate of resumption of sports activity. The graft hyper-
trophy rate was the lowest with the arthroscopic technique, 
with a reported rate of 4%, but the rate of delamination has 
not been reported.
Advances in ACI Rehabilitation
Postoperative rehabilitation has traditionally been prolonged 
long after chondrocyte implantation with empirically based 
duration of joint protection and load progression following 
the biological phases of cartilage healing and maturation.21 
While early rehabilitation protocols have focused on protec-
tion, more recent evidence has demonstrated that accelerated 
rehabilitation with early limited loading improves cartilage 
healing, knee function, and sports participation after chon-
drocyte implantation.11,22,23 Decreased invasiveness of the 
newer-generation ACI allowed for faster postoperative joint 
mobilization, accelerated neuromuscular recovery, and res-
toration of joint biomechanics. The addition of individualized 
rehabilitation programs with stepwise on-field rehabilitation 
and reintegration into the sport-specific movement and 
joint loading patterns has been successful in reducing the 
average time to return to sport from 18 months with the first-
generation ACI technique to an average of 11 months with 
the arthroscopic third-generation technique without compro-
mising the return rate or durability even in highly competi-
tive players.22
Discussion
ACI has been described as a successful technique for the 
restoration of full-thickness articular cartilage lesions in the 
knee by several investigators.7,8,16 Recent data indicate excel-
lent long-term durability of articular cartilage restoration and 
improved knee function up to 20 years postoperatively.8 This 
technique has been successfully used for articular cartilage 
repair in athletes and specifically football players.9 The good 
results in this population are encouraging because articular 
cartilage injuries are frequent in football players and often 
associated with the limited ability to play and increased risk 
for the development of knee osteoarthritis in this high-
demand athletic population, particularly at the elite level.1,4,6,24 
The increased injury rate in football players results from the 
high joint stresses associated with the repetitive joint impact 
and torsional loading seen with rapid deceleration motions, 
frequent pivoting, and player contact in football as well as the 
high incidence of ACL and meniscus injuries in this sport. 
The fact that chondrocyte transplantation in this population 
provides lasting functional improvement and return to foot-
ball demonstrates the ability of the repair cartilage tissue to 
withstand even maximum mechanical stress over time in vivo. 
Because injuries to the articular cartilage of the knee have 
been shown to present one of the most common causes of 
permanent disability in soccer players,1,3,25 successful treat-
ment of cartilage defects may be able to reduce the likelihood 
of important long-term joint dysfunction and associated loss 
of sports participation in this population.6,24
The percentage of good to excellent results observed after 
ACI in football players falls within the previously reported 
range of good to excellent results reported with this tech-
nique.8,16,26 Similar to the results in the mixed populations of 
previous studies, isolated lesions of the femoral condyle in 
the football population were associated with better outcomes. 
Significant improvement of activity scores was observed in 
more than 80% of players, confirming the overall functional 
improvements described after autologous chondrocytes in 
previous studies.8,15,26 The return rate was significantly higher 
in high-level competitive athletes than in recreational-level 
players. This phenomenon is also observed for other cartilage 
repair techniques or ACL reconstruction1,2,11,27 and can be 
attributed to the higher portion of acute lesions, younger 
age, and differences in postoperative rehabilitation, chronic 
deconditioning, and absence from competition. Higher moti-
vation, fear of reinjury, and economic and social aspects will 
also influence the difference between the return to sport in 
recreational and professional athletes.28
Return to football is significantly better if cartilage repair 
is performed within 12 months after injury.8-10 Delayed sur-
gery has been associated with significantly inferior repair 
cartilage morphology,27 which may result from the devel-
opment of degenerative joint changes if the defect is left 
untreated for too long. Experimental studies have shown a 
change in joint hemostasis with increased glycosaminogly-
can loss with delayed repair and significantly better repair 
cartilage quality with early repair.29 Early surgical treatment 
of articular cartilage lesions is therefore recommended to 
optimize postoperative joint function and sports activity.
Table 1. Factors Affecting Return to Play after Autologous 
Chondrocyte Implantation
Factor Better/faster return to play
Age Age <25 y
Preoperative interval Duration <12 mo
Athletic skill level Competitive athletes
Adjuvant procedures Simultaneous surgery
Surgical invasiveness Minimally invasive procedure
Rehabilitation Individualized sport-specific rehabilitation
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Player age affected the ability to return to football after 
chondrocyte transplantation and was also observed with 
other cartilage repair techniques.30 This effect can be attrib-
uted to the decreasing metabolic activity of chondrocytes 
with increasing age as well as change in social demands.
Average time to return to football was 18 months after first-
generation techniques. Newer second- and third-generation 
implantation techniques combined with accelerated and sport-
specific rehabilitation have allowed a marked reduction of the 
time to return to sport to an average of 11 months.22 Limited 
invasiveness of the newer implantation techniques leads to 
less surgical trauma to the joint with reduced disruption 
of joint motion, mechanoreceptors, and muscular inhibition, 
thereby accelerating recovery of the functional joint unit 
and optimizing the environment for graft stimulation and 
maturation. Improved understanding of the graft maturation 
process and the effect of gradual early graft loading has 
been one important aspect of this improvement.21-23
Importantly, chondrocyte implantation has shown the 
best durability of all cartilage repair techniques after return 
to sport, as 87% of returning players were still competing at 
a mean of 52 months postoperatively.31 This may be because 
of the improved histological tissue quality seen with this 
technique compared to other techniques.12,13 While initial 
recovery with chondrocyte transplantation may be more pro-
longed, our data suggest that this cartilage repair technique 
provides excellent durability even under very high athletic 
demands. Some world-class players were able to rapidly return 
to their preinjury level of play with excellent long-term 
durability of more than 9 years in professional football. In 
contrast to other cartilage repair procedures, this positive 
effect does not seem to be limited to small defect size or pri-
mary cartilage repair but is equally successful in large defects 
and revision situations.31,32
Hypertrophy of the grafted periosteum has been described 
in up to 26% in first-generation ACI8,16 and was associated 
with an increased rate of traumatic delamination particularly 
in high-impact pivoting sports like football.9 Technical modi-
fications such as CACI and MACI have successfully reduced 
the rate of graft hypertrophy to 4% to 7%.16,17,33 This reduced 
risk likely translates into a decreased risk for traumatic delam-
ination in athletes and facilitates more rapid activity progres-
sion and return to sport.
Concomitant injuries such as ligamentous instability 
are frequently associated with articular cartilage lesions. 
Addressing concomitant pathologies has been shown to 
improve cartilage repair and does not negatively influence 
the ability to return to sport.8,9,31 By performing all repair pro-
cedures simultaneously, repeated surgical intervention with 
prolonged rehabilitation and absence from competition can 
be avoided, and return to sport becomes more likely.
In summary, ACI has gone through a significant evolu-
tion since its first description in 1994. The first-generation 
technique demonstrated the efficacy of this cartilage repair 
procedure to return athletes to demanding sports such as 
football with excellent durability. Young, competitive play-
ers who undergo surgery within 12 months after injury will 
have the highest chance of returning to sports activity. While 
the initial ACI technique was associated with several limi-
tations because of invasiveness, frequent graft hypertro-
phy, and long intervals until return to competition, stepwise 
improvements of the surgical technique and rehabilitation 
have successfully addressed these shortcomings with reduced 
morbidity, complication rate, and accelerated return to sport 
without compromising the return rate or ability to compete 
over time.
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